The aim of this study was to explore whether YTHDF2 could be a therapeutic target for cervical cancer cells and to determine the possible mechanism of action to provide new therapeutic strategies for the treatment of cervical cancer. This evidence concerns the gene YTHDF2 and cervical carcinoma.